<DOC>
	<DOC>NCT00918398</DOC>
	<brief_summary>The primary objective is to investigate the pharmacokinetics of AZD1981 given in different formulations and to measure renal clearance</brief_summary>
	<brief_title>AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations</brief_title>
	<detailed_description />
	<criteria>Provision of informed consent prior to any study specific procedures Men or postmenopausal or surgically sterile women, aged 18 to 55 years Have a body mass index between 19 and 30 kg/m2 and weigh at least 50 kg and no more than 100 kg Be a nonsmoker or exsmoker who has stopped smoking for &gt;6 months prior to Visit 1 (preentry) Any clinically significant disease or disorder which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or influence the result of the study, or the subjectÂ´s ability to participate Any clinically relevant abnormal findings in phys.examination, clinical chemistry, haematology, urinalysis, vital signs, or ECG at baseline which, in the opinion of the investigator, may put the subject at risk because of his participation in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>